Non-Injection Chemotherapy Regimens for Drug Resistant Tuberculosis in Children and Adolescents

Non-Injection Chemotherapy Regimens for Drug Resistant Tuberculosis in Children and Adolescents

The objective: to determine the effectiveness and safety (tolerability) of non-injection chemotherapy regimens containing bedaquiline in pediatric patients with multiple drug resistant respiratory tuberculosis.Subjects and Methods. Effectiveness and safety of treatment regimens containing non-inject...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. A. Aksenova, N. I. Klevno, A. V. Kazakov, A. D. Pakhlavonova, V. A. Romanenko, N. Yu. Nikolenko
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2023-12-01
Series:	Туберкулез и болезни лёгких
Subjects:	children tuberculosis multiple drug resistant mycobacteria bedaquiline effectiveness and safety of non-injection chemotherapy regimen
Online Access:	https://www.tibl-journal.com/jour/article/view/1775
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Eﬃcacy and safety of short course chemotherapy regimens in older children and adolescents with multiple and extensive drug resistant respiratory tuberculosis
by: L. V. Panova, et al.
Published: (2021-11-01)

Use of bedaquiline in the chemotherapy regimen for multiple drug resistant tuberculosis in the HIV positive patient
by: N. D. Pirogova, et al.
Published: (2019-11-01)

IMPACT OF BEDAQUILINE ON THE EFFICIENCY OF COMPREHENSIVE THERAPY OF RESPIRATORY TUBERCULOSIS
by: M. N. Kondakova, et al.
Published: (2018-07-01)

Immediate and Postponed Results of Short-Course Chemotherapy Regimens Containing Bedaquiline in Tuberculosis Patients with Multiple Drug Resistance
by: P. N. Golubchikov, et al.
Published: (2023-08-01)

Pyrazinamide Resistance: A Major Cause of Switching Shorter to Longer Bedaquiline-based Regimens in Multidrug-resistant Tuberculosis Patients
by: Oki Nugraha Putra, et al.
Published: (2024-12-01)

EXPERIENCE OF TREATMENT OF MULTIPLE DRUG RESISTANT TUBERCULOSIS PATIENTS WITH BEDAQUILINE IN AMUR REGION
by: L. Yu. Tikhonova, et al.
Published: (2018-07-01)

EPIDEMIC SITUATION AND TREATMENT PROSPECTS OF MULTIPLE RESISTANT TUBERCULOSIS IN KANTY-MANSIYSKY AUTONOMOUS REGION
by: E. S. Ershovа, et al.
Published: (2018-05-01)

Results of treatment with bedaquiline containing regimens of MDR/XDR tuberculosis patients including those with concurrent HIV infection (the experience of Leningrad Region)
by: T. I. Danilova, et al.
Published: (2020-10-01)

The Profile of Multidrug Tuberculosis Regimen and Treatment Outcomes in Pulmonary MDR-TB Patients at the Tertiary Referral Hospital Dr. Soetomo, East Java, Indonesia: A Seven-Year Retrospective Study on Bedaquiline
by: Muhamad Frendy Setyawan, et al.
Published: (2024-01-01)

The effect of the current chemotherapy of MDR/XDR tuberculosis on QT interval changes in ECG
by: E. M. Zhukova, et al.
Published: (2019-12-01)

EFFICIENCY OF PULMONARY TUBERCULOSIS CHEMOTHERAPY IN NEW CASES DEPENDING ON THE TIME OFDRUG RESISTANCE DETECTION
by: M. V. Burаkovа, et al.
Published: (2017-12-01)

Inhalation Surfactant Therapy within Comprehensive Treatment of HIV-Infected Patients with Multiple Drug Resistant Tuberculosis
by: E. M. Zhukova, et al.
Published: (2023-10-01)

Short course treatment of pulmonary tuberculosis patients suffering from multiple drug resistance. The current situation and future perspectives
by: A. E. Russkikh, et al.
Published: (2021-01-01)

Experience of Using Bedaquiline in a Young Child with Drug Resistant Tuberculosis and Concurrent Primary Immunodeficiency
by: T. I. Danilova, et al.
Published: (2021-09-01)

Use of Short Oral Regimens for Treatment of Drug Resistant Tuberculosis in a Patient with HIV Infection
by: S. Yu. Degtyareva, et al.
Published: (2023-03-01)

EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
by: A. M. Tikhonov, et al.
Published: (2018-03-01)

Effectiveness and Safety of the Regimens Containing Bedaquiline in Patients with TB and HIV-infection
by: S. B. Borisova, et al.
Published: (2024-11-01)

The multivariate analysis of results of bedaquiline use in the therapy of MDR/XDR pulmonary tuberculosis
by: N. V. Stavitskaya, et al.
Published: (2020-08-01)

Short-Course Chemotherapy Regimens for Treatment of Multiple and Pre-Extensive Drug Resistant Tuberculosis in Combination with Surgery in Older Children and Adolescents
by: E. S. Ovsyankina, et al.
Published: (2024-12-01)

Safety of treatment regimens in multiple drug resistant tuberculosis patients compiled as per the new WHO recommendations as of 2019
by: D. A. Ivanova, et al.
Published: (2020-02-01)

Justification of Chemotherapy Duration in Patients with Multiple and Pre-Extensive Drug Resistant Tuberculosis in the Russian Federation
by: A. I. Gayda, et al.
Published: (2023-01-01)

Treatment success and mortality among people with multi-drug resistant and rifampicin resistant-tuberculosis on bedaquiline-based regimen at three referral hospitals in Uganda: A retrospective analysis
by: Lodiong Jackson Dumo Lodiong, et al.
Published: (2024-12-01)

Comparative analysis of eﬃcacy and safety of various anti-tuberculosis therapy regimens in patients with MDR/XDR tuberculosis
by: E. P. Myshkova, et al.
Published: (2022-06-01)

High Prevalence of atpE Mutations in Bedaquiline-Resistant Mycobacterium tuberculosis Isolates, Russia
by: Danila Zimenkov, et al.
Published: (2025-03-01)

Preventive chemotherapy in children exposed to multiple drug resistant tuberculosis
by: V. A. Аksenova, et al.
Published: (2019-07-01)

Treatment success using novel and adapted treatment regimens in registered DR-TB children in Dushanbe, Tajikistan, 2013-2019
by: Bobojon Pirmahmadzoda, et al.
Published: (2021-09-01)

Experience of treating extensive drug resistant tuberculosis patients including continuous use of bedaquiline, in Tomsk Region: immediate and postponed results
by: P. N. Golubchikov, et al.
Published: (2019-09-01)

EXPERIENCE OF TREATING MULTIPLE AND EXTENSIVE DRUG RESISTANT TUBERCULOSIS WITH NEW REGIMENS IN BELARUS REPUBLIC
by: E. M. Skryagina, et al.
Published: (2018-09-01)

Efficacy and safety of bedaquiline in treatment regimens in patients TB/HV co-infection in the Udmurt Republic
by: O. E. Russkikh, et al.
Published: (2023-04-01)

Algorithm for assigning different 6-month short-term chemotherapy regimens in patients with drug-resistant tuberculosis: how to make the right choice for the clinician
by: Yu.I. Feshchenko, et al.
Published: (2025-06-01)

Experience of using two courses of bedaquiline in the adolescent with extensive drug resistant fibrous cavernous tuberculosis
by: L. V. Pаnovа, et al.
Published: (2019-08-01)

Tolerability and Efficacy of Chemotherapy Containing Bedaquiline in Patients with Multiple Drug Resistant Pulmonary Tuberculosis
by: O. V. Filinyuk, et al.
Published: (2022-10-01)

THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)

Toxicity of treatment regimens for drugresistant tuberculosis.
by: G. N. Mozhokina, et al.
Published: (2022-03-01)

New drugs in the treatment of drug-resistant tuberculosis in children. Experience with the use of delamanid in combination with bedaquiline
by: Ekaterina Sokolskaya, et al.
Published: (2024-12-01)

Short course chemotherapy in children suffering from drug resistant tuberculosis
by: N. I. Klevno, et al.
Published: (2021-03-01)

Experience of using bedaquiline in the treatment of pulmonary tuberculosis patients with multiple drug resistance
by: T. I. Morozova, et al.
Published: (2016-02-01)

Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance
by: N. Yu. Nikolenko, et al.
Published: (2023-07-01)

INDIVIDUAL APPROACHES TO THE CHOICE OF CHEMOTHERAPY REGIMENS FOR RESPIRATORY TUBERCULOSIS IN CHILDREN EXPOSED TO MULTIPLE DRUG RESISTANT TUBERCULOUS INFECTION
by: M. F. Gubkina, et al.
Published: (2016-09-01)

ECONOMIC FEASIBILITY OF NEW CHEMOTHERAPY REGIMENS FOR TREATMENT OF TUBERCULOSIS PATIENTS WITH EXTENSIVE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2018-07-01)